About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Botulinum toxin a
- Procedure number
- PSUSA/00000426/202112
- Regulatory outcome
- Variation
Documents
Botulinum toxin a : List of nationally authorised medicinal products - PSUSA/00000426/202112
English (EN) (435.13 KB - PDF)
Botulinum toxin a : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00000426/202112
English (EN) (75.9 KB - PDF)
български (BG) (77.98 KB - PDF)
español (ES) (78.53 KB - PDF)
čeština (CS) (80.86 KB - PDF)
dansk (DA) (79.01 KB - PDF)
Deutsch (DE) (83.73 KB - PDF)
eesti keel (ET) (71.31 KB - PDF)
ελληνικά (EL) (75.88 KB - PDF)
français (FR) (78.32 KB - PDF)
hrvatski (HR) (77.31 KB - PDF)
íslenska (IS) (78.98 KB - PDF)
italiano (IT) (89.27 KB - PDF)
latviešu valoda (LV) (93.84 KB - PDF)
lietuvių kalba (LT) (86.63 KB - PDF)
magyar (HU) (80.29 KB - PDF)
Malti (MT) (84.4 KB - PDF)
Nederlands (NL) (78.72 KB - PDF)
norsk (NO) (76.71 KB - PDF)
polski (PL) (81.12 KB - PDF)
português (PT) (49.4 KB - PDF)
română (RO) (77.15 KB - PDF)
slovenčina (SK) (82.93 KB - PDF)
slovenščina (SL) (76.48 KB - PDF)
Suomi (FI) (73.43 KB - PDF)
svenska (SV) (77.77 KB - PDF)